Excellent Result With the Use of Single-Dose OK-432 in Cervical Macrocystic Lymphangioma
 
Yazarlar (7)
Nihal Efe
Enver Altas
Muhammet Recai Mazlumoglu
Bulent Aktan
Harun Ucuncu
Suat Eren
Makale Türü Özgün Makale (SSCI, AHCI, SCI, SCI-Exp dergilerinde yayınlanan tam makale)
Dergi Adı JOURNAL OF CRANIOFACIAL SURGERY (Q4)
Dergi ISSN 1049-2275 Dergi Bilgileri (2016)
Makale Dili İngilizce Basım Tarihi 10-2016
Cilt / Sayı / Sayfa 27 / 7 / 1802–1803 DOI 10.1097/SCS.0000000000002983
Makale Linki https://journals.lww.com/jcraniofacialsurgery/fulltext/2016/10000/Excellent_Result_With_the_Use_of_Single_Dose.46.aspx
UAK Araştırma Alanları
Özet
Though the lymphangioma is a benign neoplasm, it may make an invasion to vital structures by progressively growing. For lymphangioma, which progressed in such a way, surgical treatment has high morbidity and recurrence risk. On these cases, OK-432 is a frequently used sclerotherapy agent. The authors report the result they obtained by the use of single-dose OK-432 on an inoperable pediatric cervical macrocystic lymphangioma case and also their experiences.
Anahtar Kelimeler
Cervical macrocystic lymphangioma | OK-432 | sclerotherapy
BM Sürdürülebilir Kalkınma Amaçları
Atıf Sayıları
Web of Science 7
Google Scholar 9
Excellent Result With the Use of Single-Dose OK-432 in Cervical Macrocystic Lymphangioma

Paylaş